Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,088 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TP53 Mutations are Associated with CD19 Negative Relapse and Inferior Outcomes after Blinatumomab in Adults with ALL.
Aldoss I, Li S, Zhang J, Clark MC, Agrawal V, Pourhassan H, Koller PB, Aribi A, Ali H, Blackmon A, Otoukesh S, Sandhu KS, Ball BJ, Arslan S, Artz AS, Amanam I, Al Malki MM, Salhotra A, Kovacsovics TJ, Murphy LA, Afkhami M, Ngo D, Tinajero J, Gu Z, Becker PS, Nakamura R, Stein AS, Marcucci G, Forman SJ, Pullarkat VA. Aldoss I, et al. Among authors: arslan s. Blood Adv. 2025 Jan 16:bloodadvances.2024014986. doi: 10.1182/bloodadvances.2024014986. Online ahead of print. Blood Adv. 2025. PMID: 39820649
Fludarabine melphalan reduced intensity conditioning vs radiation-based myeloablative conditioning in patients undergoing allogeneic transplantation for acute myeloid leukemia with measurable residual disease.
Blackmon A, Afkhami M, Yang D, Mokhtari S, Samara Y, Pourhassan H, Ball B, Salhotra A, Agrawal V, Sandhu K, Desai A, Otoukesh S, Arslan S, Amanam I, Koller P, Tinajero J, Aribi A, Aldoss I, Becker P, Artz A, Ali H, Stein A, Smith E, Pullarkat V, Forman SJ, Marcucci G, Nakamura R, Al Malki MM. Blackmon A, et al. Among authors: arslan s. Bone Marrow Transplant. 2024 Dec 18. doi: 10.1038/s41409-024-02491-0. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39695333
Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD).
Pourhassan H, Nguyen T, Yang D, Otoukesh S, Arslan S, Blackmon A, Agrawal V, Amanam I, Ball B, Koller P, Salhotra A, Aribi A, Becker P, Curtin P, Artz A, Aldoss I, Ali H, Stewart F, Smith E, Stein A, Marcucci G, Forman SJ, Nakamura R, Al Malki MM. Pourhassan H, et al. Among authors: arslan s. Cancers (Basel). 2024 Nov 22;16(23):3912. doi: 10.3390/cancers16233912. Cancers (Basel). 2024. PMID: 39682101 Free PMC article.
1,088 results